,i #aahth ,,congress #ast ,session ,h4 ,r4 #fbdc ,,in ,,the ,,house ,,of ,,representatives ,november #f1 #bjbc,mr4 ,gallego 7for himself and ,mr4 ,nunn of ,iowa7 introduced the following bill2 which was referred to the ,committee on ,education and the ,workforce1 and in addition to the ,committee on the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to direct the ,secretary of ,labor to issue an occupational safety and health standard that requires employers to keep opioid overdose reversal drugs onsite and develop and implement training plans to respond to drug overdose emergencies and to amend the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh to expand the grants authorized under the ,comprehensive ,opioid ,abuse ,grant ,program4 #a4 ,short title ,this ,act may be cited as the ,overdose ,reversal ,medication ,act or the ,,orm ,act4 #b4 ,opioid overdose reversal drug standard 7a7 ,interim ,final ,standard 7#a7 ,in general ,not later than #a year after the date of enactment of this ,act1 the ,secretary of ,labor shall issue an interim final standard on workplace availability of an opioid overdose reversal drug or device-- 7,a7 to require all employers to possess an opioid overdose reversal drug or device on site1 where the required number of doses of such drug or device required is determined on the basis of the number of employees of the employer on site1 type of occupation1 and an assessment of potential use2 7,b7 that establishes guidelines for training on-- 7i7 identifying signs and symptoms indicating that usage of an opioid overdose drug or device is necessary2 and 7ii7 how to administer such opioid overdose reversal drug or device2 and 7,c7 that provides for a period as determined appropriate by the ,secretary1 not to exceed #a year1 during which the ,secretary shall prioritize technical assistance and advice consistent with section #ba7;d7 of the ,occupational ,safety and ,health ,act of #aigj 7#bi ,u4,s4,c4 #fgj7;d77 to employers subject to the standard with respect to compliance with the standard4 7#b7 ,effective date of interim standard ,the interim final standard shall-- 7,a7 take effect on a date that is not later than #cj days after issuance2 7,b7 shall have the same legal effect as an occupational safety and health standard as defined by section #c of the ,occupational ,safety and ,health ,act of #aigj 7#bi ,u4,s4,c4 #feb72 and 7,c7 be in effect until the final standard described in subsection 7b7 becomes effective and enforceable4 7#c7 ,failure to promulgate ,if an interim final standard described in paragraph 7#a7 is not issued by the date that is #a year after the date of enactment of this ,act1 the provisions of this ,act shall be in effect and enforced in the same manner and to the same extent as any standard promulgated under section #f7;b7 of the ,occupational ,safety and ,health ,act 7#bi ,u4,s4,c4 #fee7;b77 until such provisions are superseded in whole by an interim final standard issued by the ,secretary that meets the requirements of paragraph 7#a74 7b7 ,final standard ,not later than #b years after the date of enactment of this ,act1 the ,secretary of ,labor shall1 pursuant to section #f of the ,occupational ,safety and ,health ,act 7#bi ,u4,s4,c4 #fee71 promulgate a final standard on workplace availability of opioid overdose reversal drugs or devices-- 7#a7 for the purposes described in subsection 7a77#a77;,a72 7#b7 that shall include1 at a minimum1 requirements contained in the interim final standard promulgated under subsection 7a72 and 7#c7 be effective and enforceable in the same manner and to the same extent as any standard promulgated under section #f7;b7 of the ,occupational ,safety and ,health ,act of #aigj 7#bi ,u4,s4,c4 #fee7;b774 7c7 ,definitions ,in this section3 7#a7 ,employee2 employer ,the terms employee and employer have the meaning given such terms in section #c of the ,occupational ,safety and ,health ,act of #aigj 7#bi ,u4,s4,c4 #feb74 7#b7 ,opioid overdose reversal drug or device ,the term opioid overdose reversal drug or device means an opioid overdose reversal drug or device approved1 licensed1 cleared1 or otherwise authorized for marketing by the ,food and ,drug ,administration4 7#c7 ,secretary ,the term ,secretary means the ,secretary of ,labor4 #c4 ,expansion of the ,comprehensive ,opioid ,abuse ,grant ,program ,section #cjba of title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#cd ,u4,s4,c4 #ajgja7;a77 is amended-- 7#a7 in subsection 7a71 by adding at the end the following3 7#aa7 ,developing1 implementing1 or expanding a program 7which may include demonstration projects7 that-- 7,a7 provides training on carrying and administering an opioid overdose reversal drug or device approved1 licensed1 cleared1 or otherwise authorized for marketing by the ,food and ,drug ,administration for local businesses1 individuals1 or other community entities that are likely to encounter individuals with substance use disorders1 but are not eligible for other ,federal grant programs or to receive training or resources under such a grant program related to substance use prevention and treatment2 or 7,b7 provides resources for employers1 individuals1 or community entities described in subparagraph 7,a7 who have received training described in subparagraph 7,a7 to acquire1 carry1 and administer such a drug or device4 2 and 7#b7 by adding at the end the following3 7g7 ,preferential consideration ,in awarding grants under this part1 the ,attorney ,general may give preferential consideration to an application from an applicant in a ,state that has in effect a law that exempts from criminal and civil liability individuals who carry or administer in good faith an opioid overdose reversal drug or device approved1 licensed1 cleared1 or otherwise authorized for marketing by the ,food and ,drug ,administration1 if such an individual has been trained to carry or administer such drug or device4 4